|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 277 | 2005 | Osteoporosis and fall risk in patients with fragility fractures | van Helden, SH; Nieuwenhuijzen-Kruseman, AC; Dinant, G; Pijpers, E; ten Broeke, R; Brink, PR; GEUSENS, Piet | Journal Contribution | M |
| 278 | 2005 | Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures | Hochberg, M.C.; Thompson, D.E.; Black, D.M.; Quandt, S.A.; Cauley, J.; GEUSENS, Piet; Ross, P.D.; Baran, D. | Journal Contribution | A1 |
| 279 | 2005 | Premature senescence of the immune system in rheumatoid arthritis and multiple sclerosis patients. | LINSEN, Loes; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | M |
| 280 | 2005 | Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis | LINSEN, Loes; THEWISSEN, Marielle; BAETEN, Kurt; SOMERS, Veerle; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | A1 |
| 281 | 2005 | Cost-effectiveness analysis of Aclasta in Paget's disease of bone in Belgium | Lecomte, P; Devogelaer, JP; Kaufman, JM; Goemaere, S; Engbersen, A; GEUSENS, Piet | Journal Contribution | M |
| 282 | 2005 | Synovial fluid NKT cells display different properties compared to peripheral blood NKT cells in rheumatoid arthritis | LINSEN, Loes; SOMERS, Veerle; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | M |
| 283 | 2005 | A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids | van Staa, TP; GEUSENS, Piet; Pols, HAP; de Laet, C; Leufkens, HGM; Cooper, C | Journal Contribution | A1 |
| 284 | 2005 | Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: Reduction in risk of nonvertebral fracture is not related to change in BMD | Watts, N.B.; GEUSENS, Piet; Barton, I.; Felsenberg, D. | Journal Contribution | A1 |
| 285 | 2005 | Newer drug treatments: Their effects on fracture prevention | GEUSENS, Piet; Reid, D | Journal Contribution | A1 |
| 286 | 2005 | The effect of infliximab therapy on bone mineral density in patients with ankylosing spondylitis: Results from ASSERT | Deodhar, A; Han, J; Williamson, P; Braun, J; VAN DER HEIJDE, Desiree; GEUSENS, Piet | Journal Contribution | M |
| 287 | 2004 | Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis | Landewe, R; GEUSENS, Piet; Boers, M; VAN DER HEIJDE, Desiree; Lems, W; Koppele, JT; van der Linden, S; Garnero, P | Journal Contribution | A1 |
| 288 | 2004 | Ankylosing spondylitis and the risk of fracture. | Vosse, D; van der Linden, S; Cooper, C; van Staa, TP; GEUSENS, Piet; VAN DER HEIJDE, Desiree | Journal Contribution | M |
| 289 | 2004 | Case-finding van osteoporose in de dagelijkse praktijk: snel en efficiënt op basis van de CBO-richtlijn: verslag van een rondetafelbijeenkomst | GEUSENS, Piet; van der Voort, D.J.M.; Elders, P.J.M.; Dinant, G.J. | Journal Contribution | A3 |
| 290 | 2004 | Comparing antifracture efficacy of antiresorptive agents | GEUSENS, Piet | Journal Contribution | A2 |
| 291 | 2004 | Interactie tussen osteoporose en vallen en het risico van fracturen | GEUSENS, Piet | Journal Contribution | A3 |
| 292 | 2004 | Reumatologie en klinische immunologie | GEUSENS, Piet; Bijlsma, J.W.J.; Kallenberg, C.G.M.; Tak, P.P.; Jacobs, J.W.G. | Book | B1 |
| 293 | 2004 | Animal studies | GEUSENS, Piet; Zhao, J.; Jiang, Y.; Njeh, C.F.; Bouillon, R.; Genant, H.K. | Book Section | B2 |
| 294 | 2004 | Osteoporosis in Clinical Practice | Sambrook, P.; GEUSENS, Piet; Lindsay, R. | Book | B1 |
| 295 | 2004 | Complex regionaal pijnsyndroom | GEUSENS, Piet; van den Brink, H.R. | Book Section | B2 |
| 296 | 2004 | The safety and efficacy of infliximab in RA: 1-year results of a large, randomized, placebo-controlled trial in patients with various comorbidities and background treatments as encountered in clinical practice. | Yocum, D; Wolfe, F; Rahman, MU; Han, J; Berman, A.; Strusberg, I; Westhovens, R; GEUSENS, Piet | Journal Contribution | M |
| 297 | 2004 | Behandeling van postmenopauzale osteoporose: hoe behandelingen te vergelijken? | GEUSENS, Piet | Journal Contribution | A3 |
| 298 | 2004 | Klinische betekenis van specifieke en niet-specifieke medische condities voor het vaststellen van osteoporose | GEUSENS, Piet; van der Voort, D.J.M.; Dinant, G.J. | Journal Contribution | A3 |
| 299 | 2004 | Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial | Schnitzer, TJ; Beier, J.; GEUSENS, Piet; Hasler, P; Patel, SK; Senftleber, I; Gitton, X; Moore, A.; Sloan, VS; Poor, G | Journal Contribution | A1 |
| 300 | 2004 | Osteoporosis: clinical features | GEUSENS, Piet | Journal Contribution | A3 |
| 301 | 2004 | Metabole botziekten | GEUSENS, Piet; Laan, R.F.J.M.; Lems, W.F.; Goemaere, G. | Book Section | B3 |
| 302 | 2004 | Performance of the OST risk tool for identifying men at risk of osteoporosis | GEUSENS, Piet; Hochberg, MC; Adler, Robert A. | Journal Contribution | M |
| 303 | 2004 | The relationship between vertebral wedging in the thoracic spine and the occiput-to-wall-distance (OWD) in ankylosing spondylitis (AS) patients | Vosse, D; Landewe, RBM; Van der Linden, S; GEUSENS, Piet; VAN DER HEIJDE, Desiree | Journal Contribution | M |
| 304 | 2004 | Osteoporosis: Diagnosis and guidelines | GEUSENS, Piet | Journal Contribution | M |
| 305 | 2004 | Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology | GEUSENS, Piet; de Nijs, RNJ; Lems, WF; Laan, RFJM; Struijs, A; van Staa, TP; Bijlsma, JWJ | Journal Contribution | A1 |
| 306 | 2004 | Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a 24-week randomized, placebo-controlled trial (ASSERT) | Dijkmans, B; Sieper, J; DeWoody, K; Williamson, R; Braun, J; VAN DER HEIJDE, Desiree; GEUSENS, Piet | Journal Contribution | M |
| 307 | 2004 | Risk factors for bone loss in women with early, active rheumatoid arthritis: A prospective study in the COBRA trial | GEUSENS, Piet; Landewe, R; Garnero, P; Verhoeven, A; Boers, M; van der Linden, S | Journal Contribution | M |
| 308 | 2004 | A cross-sectional study of postmenopausal women found an association between osteoporosis and past gastric surgery or oral corticosteroids | van der Voort, DJM; GEUSENS, Piet; Dinant, GJ | Journal Contribution | A1 |
| 309 | 2004 | The cost-effectiveness of bone protection in patients using oral glucocorticoids. | van Staa, TP; Leufkens, H; Pols, H; Cooper, C; GEUSENS, Piet | Journal Contribution | M |
| 310 | 2004 | The lunar achilles as a screening tool for osteoporosis: Comparison with spine DXA | Poriau, S; GEUSENS, Piet; Van den Bosch, F; De Keyser, F | Journal Contribution | M |
| 311 | 2004 | Osteoporosis screening: Comparison of heel ultrasound measurement to calculated risk assessment | Poriau, S; Van den Bosch, F; De Keyser, F; GEUSENS, Piet | Journal Contribution | M |
| 312 | 2004 | Musculoskeletal rehabilitation in osteoporosis: A review | Pfeifer, M; Sinaki, M; GEUSENS, Piet; Boonen, S; Preisinger, E; Minne, H.W. | Journal Contribution | A1 |
| 313 | 2004 | The estimation of the 5-year probability of fracture in a general population of elderly women. | van Staa, TP; Leufkens, H; Gehlbach, S; Cooper, C; GEUSENS, Piet | Journal Contribution | M |
| 314 | 2004 | Effect of choline stabilized orthosilicic acid on bone density in ovariectomized rats. | Calomme, M; Sindambiwe, J; Cos, P; Vyncke, C; GEUSENS, Piet; VAN DEN BERGHE, David | Journal Contribution | M |
| 315 | 2004 | Clinical vertebral fractures in patients with ankylosing spondylitis | Vosse, D; Feldtkeller, E; Erlendsson, J; van der Linden, S; GEUSENS, Piet | Journal Contribution | A1 |
| 316 | 2004 | Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand mRNA expression in patients with rheumatoid arthritis and healthy controls | VANDER BORGHT, Ann; LINSEN, Loes; THEWISSEN, Marielle; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | A1 |
| 317 | 2004 | Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis | GEUSENS, Piet; Alten, R.; Rovensky, J; Sloan, VS; Krammer, G; Kralidis, G; Richardson, P | Journal Contribution | A1 |
| 318 | 2004 | Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX (R) versus EVISTA (R) Comparison Trial) International | Sambrook, PN; GEUSENS, Piet; Ribot, C; Solimano, JA; Ferrer-Barriendos, J; Gaines, K; Verbruggen, N; Melton, ME | Journal Contribution | A1 |
| 319 | 2004 | Fracture incidence after fragility fractures admitted to the hospital | van Helden, SH; Bulstra, S; Brink, PRG; Koeyers, W; GEUSENS, Piet | Journal Contribution | M |
| 320 | 2003 | Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis: Results of a randomized double-blind study | GEUSENS, Piet; Alten, R.; Rovensky, J; Sloan, V; Krammer, G; Kralidis, G; Richardson, P | Journal Contribution | M |
| 321 | 2003 | Botdensitometrie | Boonen, S.; GEUSENS, Piet; Luyken, F.; Vanderschueren, D. | Book Section | B2 |
| 322 | 2003 | De plaats van bisfosfonaten in de behandeling van osteoporose | GEUSENS, Piet | Journal Contribution | A3 |
| 323 | 2003 | Falls and fractures in postmenopausal women: a review | GEUSENS, Piet; Milisen, Koen; Dejaeger, E.; Boonen, S. | Journal Contribution | A2 |
| 324 | 2003 | Toepasbaarheid van een algoritme voor snelle detectie van patiënten met een lage botmineraaldichtheid in de huisartspraktijk | GEUSENS, Piet; van der Voort, D.J.M.; Dinant, G.J.; Rinkens, P.E.L.M.; van der Voort-Duindam, C.J.M.; van Wersch, J.E.J. | Journal Contribution | A3 |
| 325 | 2003 | Nieuwe inzichten in de relatie tussen botweefsel en ontsteking: het voorbeeld van reumatoïde artritis | GEUSENS, Piet; Lems, W.; Landewé, R. | Journal Contribution | A3 |
| 326 | 2003 | Risedronate once a week: a viewpoint | GEUSENS, Piet | Journal Contribution | A3 |
| 327 | 2003 | High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and antitumour necrosis factor inhibitors | VANHOOF, Johan; Landewe, S; Van Wijngaerden, E; GEUSENS, Piet | Journal Contribution | A1 |
| 328 | 2003 | Serum levels of receptor activator of nuclear factor kappa-beta (RANK)-ligand (L) and osteoprotegerin (OPG) independently predict long-term radiographic progression in patients with early rheumatoid arthritis (RA) | Boers, M; Van der Linden, S; Garnero, P; Landewe, R; GEUSENS, Piet; VAN DER HEIJDE, Desiree; LINSEN, Loes | Journal Contribution | M |
| 329 | 2003 | Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients | Codreanu, C; Combe, B; Fiocco, U; Gaubitz, M; Kvien, T; Pavelka, K; Sambrook, P; Smolen, J; Williams, BD; Appel, A.M.; GEUSENS, Piet | Journal Contribution | M |
| 330 | 2003 | Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age | Braam, L.A.J.L.M.; Knapen, M.H.J.; GEUSENS, Piet; Brouns, F.; Hamulyák, K.; Gerichhausen, M.J.W.; Vermeer, C. | Journal Contribution | A1 |
| 331 | 2003 | Biochemical markers of joint tissue turnover in early rheumatoid arthritis | Garnero, P; GEUSENS, Piet; Landewe, R | Journal Contribution | A1 |
| 332 | 2003 | Clinical use of a simple risk tool can improve case-finding for osteoporosis | GEUSENS, Piet; Pols, H; Melton, M; Hochberg, MC; van der Voort, D; van der Klift, M; Ross, PD | Journal Contribution | M |
| 333 | 2003 | Interaction between falls and clinical fractures. | GEUSENS, Piet | Journal Contribution | M |
| 334 | 2003 | Risk of gastrointestinal events with bisphosphonates: Rating the evidence | GEUSENS, Piet; Rizzoli, R; Sambrook, P; Schnitzer, T | Journal Contribution | M |
| 335 | 2003 | Greater increases in bone mineral density with alendronate compared to raloxifene: Results from effect-international | Sambrook, P; Ferrer-Barriendos, J; Ribot, C; Solimano, JA; Verbruggen, N; Gaines, K; Melton, ME; GEUSENS, Piet | Journal Contribution | M |
| 336 | 2003 | Femoral neck mechanical quality and MR microscopic Imaging of a postmenopausal osteoporosis model in ewes treated with calcitonin. | Jiang, Y; Zhao, JJ; Lynch, JA; Ouyang, X; Azria, M.; Genant, HK; GEUSENS, Piet; ADRIAENSENS, Peter; GELAN, Jan | Journal Contribution | M |
| 337 | 2003 | Factors affecting bone loss in female endurance athletes - A two-year follow-up study | Braam, L.A.J.L.M.; Knapen, M.H.J.; GEUSENS, Piet; Brouns, F.; Vermeer, C. | Journal Contribution | A1 |
| 338 | 2003 | An exceptional radiographic presentation of bilateral insufficiency fractures of the proximal tibia in a patient with rheumatoid arthritis | VANHOOF, Johan; Landewe, S; VANDEVENNE, Jan; GEUSENS, Piet | Journal Contribution | A1 |
| 63 | 2003 | Efficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 months | Sambrook, P; GEUSENS, Piet; Keraudren, V; Gaines, K; Leung, A; Melton, M | Journal Contribution | M |
| 64 | 2003 | Review of guidelines for testing and treatment of osteoporosis | GEUSENS, Piet | Journal Contribution | A2 |
| 65 | 2002 | Osteoporosis and the growth hormone-insulin-like growth factor axis | GEUSENS, Piet; Boonen, S | Journal Contribution | A1 |
| 66 | 2002 | Short-term reduction in urinary CTX-II, a marker of cartilage degradation, predicts long-term radiological progression in patients with rheumatoid arthritis (RA) treated with disease-modifying antirheumatic therapy (DMARD). | Gamero, P; Landewe, RBM; Boers, M; Christgau, S; van der Linden, SJ; VAN DER HEIJDE, Desiree; GEUSENS, Piet | Journal Contribution | M |
| 67 | 2002 | Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis - The COBRA Study | Garnero, P; Landewe, R; Boers, M; Verhoeven, A; van der Linden, S; Christgau, S; Boonen, A; VAN DER HEIJDE, Desiree; GEUSENS, Piet | Journal Contribution | A1 |
| 68 | 2002 | Receptor activator of the nuclear factor kappa-b ligand (RANKL) in the serum of patients with RA is strongly coupled to rheumatoid-factor presence, and predicts long-term radiologic progression. | GEUSENS, Piet; Landewe, R; Dunstan, C; Gaenero, P; van der Linden, S; Boers, M | Journal Contribution | M |
| 69 | 2002 | Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis. | Combe, BG; Codreanu, C; Fiocco, U; Gaubitz, M; Kvien, TK; Pavelka, K; Sambrook, PN; Smolen, JS; Williams, BD; Appel, A.M.; GEUSENS, Piet | Journal Contribution | M |
| 70 | 2002 | Ronde tafel bijeenkomst: preventie en behandeling van glucocorticosteroïd geïnduceerde osteoporose | GEUSENS, Piet; de Nijs, R.N.J.; Bijlsma, J.W.J.; Laan, R.F.J.M.; Lems, W.F.; Struijs, A.; van Staa, T.P. | Journal Contribution | A3 |
| 71 | 2002 | Epidemiologie van osteoporose | GEUSENS, Piet | Journal Contribution | A3 |
| 72 | 2002 | Anabole therapieën bij osteoporose | GEUSENS, Piet | Journal Contribution | A3 |
| 73 | 2002 | Effect of choline stabilized orthosilicic acid on bone density in chicks | MERTENS, Johan; GEUSENS, Piet; Calomme, M.; Wijnen, P.; Sindambiwe, J.; Cos, P.; VAN DEN BERGHE, David | Journal Contribution | A3 |
| 74 | 2002 | Clinical modelling application of finger mathematical | VAN ZWIETEN, Koos Jaap; LIPPENS, Peter; GEUSENS, Piet; Kowalski, M.; Sholukha, V.A.; Zinkovsky, A.V. | Journal Contribution | A3 |
| 75 | 2002 | The relationship among history of falls, osteoporosis, and fractures in postmenopausal women | GEUSENS, Piet; Autier, P; VANHOOF, Johan; Declerck, K; RAUS, Jef | Journal Contribution | A1 |
| 76 | 2002 | Prevalence of rheumatic diseases in a rheumatological outpatient practice | VANHOOF, Johan; Declerck, K; GEUSENS, Piet | Journal Contribution | A1 |
| 77 | 2002 | A cross-sectional study of treated and untreated postmenopausal women using the IMMULITE (R) automated immunoassay system. | Vankrieken, L; Beukeveld, J; Schreurs, C; Dinant, GJ; Durham, AP; El Shami, AS; GEUSENS, Piet | Journal Contribution | M |
| 78 | 2002 | A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis | GEUSENS, Piet; Truitt, K.; Sfikakis, P.; Zhao, P.L.; DeTora, L.; Shingo, S.; Lau, C.S.; Kalla, A.; Tate, G. | Journal Contribution | A1 |
| 79 | 2002 | Ankylosing spondylitis is a strong risk factor for vertebral fractures | Vosse, D; van der Linden, S; GEUSENS, Piet; VANHOOF, Johan | Journal Contribution | M |
| 80 | 2002 | Risedronate reduces the risk of first vertebral fracture in osteoporotic women as soon as 1 year. | GEUSENS, Piet; Heaney, R; Chesnut, C; Cros, M; BOS, Kim | Journal Contribution | M |
| 81 | 2002 | Osteoporosis in clinical practice. One-year survey in a rheumatological unit | GEUSENS, Piet; VANHOOF, Johan | Journal Contribution | M |
| 82 | 2002 | Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: Effects of treatment with cyclosporin A (Neoral (R)) | VANDER BORGHT, Ann; De Keyser, F.; De Backer, M.; Malaise, M.; Baeten, D.; Van den Bosch, F.; Veys, E.M.; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | A1 |
| 83 | 2002 | A simple chart for evaluating risk of osteoporosis based on the Osteoporosis Self-Assessment Tool (OST) | GEUSENS, Piet; Pols, H; Siris, E; Hochberg, MC; Ross, PD | Journal Contribution | M |
| 84 | 2002 | Effects of risedronate on risk of femoral neck and intertrochanteric fractures | Adami, S.; Bensen, W.G.; Miller, Paul D.; Meunier, P; GEUSENS, Piet | Journal Contribution | M |
| 85 | 2002 | Risedronate reduces the risk of first vertebral fracture in osteoporotic women | Heaney, RP; Zizic, TM; Fogelman, I; Olszynski, WP; GEUSENS, Piet; Kasibhatla, C; Alsayed, N.; Isaia, G; Davie, MW; Chesnut, CH | Journal Contribution | A1 |
| 86 | 2002 | Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: A double-blind, placebo-controlled pilot study | Boonen, S; Rosen, C; Bouillon, R; Sommer, A; McKay, M; Rosen, D; Adams, S.; Broos, P; Lenaerts, J; RAUS, Jef; Vanderschueren, D; GEUSENS, Piet | Journal Contribution | A1 |
| 87 | 2002 | Performance of risk indices for identifying low bone density in postmenopausal women | GEUSENS, Piet; Hochberg, MC; van der Voort, DJM; Pols, H; van der Klift, M; Siris, E; Melton, ME; Turpin, J; Byrnes, C; Ross, PD | Journal Contribution | A1 |
| 88 | 2002 | Skeletal benefits are maintained through 7 years of alendronate treatment | Weinstein, RS; Meunier, P.J.; Bone, H; Tonino, RP; Ross, PD; Santora, A; GEUSENS, Piet | Journal Contribution | M |
| 89 | 2002 | Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation? | BUNTINX, Mieke; AMELOOT, Marcel; STEELS, Paul; JANSSEN, Paul; MEDAER, Rob; GEUSENS, Piet; RAUS, Jef; STINISSEN, Piet | Journal Contribution | A1 |
| 90 | 2001 | Review of risedronate and its clinical application in the treatment of postmenopausal and glucocorticoid-induced osteoporosis | GEUSENS, Piet; McClung, Michael | Journal Contribution | A2 |
| 91 | 2001 | Osteoporose: tussen wait and see en see and screen | GEUSENS, Piet; Dinant, G.J.; van der Voort, D.J.M. | Book Section | B3 |
| 92 | 2001 | Corticosteroïden geïnduceerde osteoporose: de beste behandeling is de preventie. Nut van bisfosfonaten: het voorbeeld van etidronaat | GEUSENS, Piet; Gangji, Valerie | Journal Contribution | A3 |
Loading...
5
0
5
0
false